This Solicitation opportunity from Department Of Defense was posted on August 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

DIBUCAINE OINTMENT

Closed

SPE2DP-26-T-4800Federal

Submission Closed09/08/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Hydrogen Peroxide Topical Solution Manufacturer

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Benzoin Tincture Impregnated Applicators

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Manufacturer of Globulin, Rho (D) Immune

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Miconazole Nitrate Antifungal Foot Powder

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Tolnaftate Powder (USP 1%)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Psyllium Hydrophilic Mucilloid Supply

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4957

This contract is for the procurement of Benzonatate Capsules, USP, 100 mg, provided in bottles of 100 units. The items must be stored at a controlled room temperature between 20 and 25 degrees Celsius and protected from light, moisture, and humidity. The order consists of two bottles under NSN 6505006601798, with a non-extendable shelf life of 36 months. The agreement specifies a delivery timeframe of 20 days after receipt of the order, with FOB destination for both inspection and acceptance. Compliance with FDA regulations, DLA packaging requirements, and Medical Marking Standard No. 1 is mandatory. The solicitation is managed by the Department of Defense Medical Supply Chain Pharmacy FSA under contract number SPE2DP-26-T-4957.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4955

This contract, identified as SPE2DP-26-T-4955, is for the procurement of Famotidine Tablets, 20 mg, in unit dose packages of 100 tablets. The requirement includes two line items with a total quantity of 15 packages, delivered FOB destination to locations in Baumholder, Germany. The drug is FDA regulated and must adhere to a non-extendable shelf-life requirement of 30 months. Compliance with DLA packaging and marking standards is mandatory, specifically Medical Marking Standard No. 1 and RP001 for palletization. All items must be secured in sealed unit containers and commercial exterior shipping containers to prevent damage. Delivery is required within 10 days, with required delivery dates set for September 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4951

This contract, identified as SPE2DP-26-T-4951, is for the procurement of Isoniazid Tablets USP, 300 mg, supplied in bottles of 100. The drug is FDA regulated and requires storage at medical controlled room temperature. The agreement specifies a non-extendable shelf life of 36 months and mandates compliance with the latest Medical Marking Standard No. 1 and DLA packaging requirements. Additionally, the contract prohibits the intentional addition of mercury or mercury-containing compounds to the supplies. The order consists of three line items totaling nine bottles, distributed across three different vessels: the USS Kidd, USS Roosevelt, and USS Canberra. Delivery is required within 20 days, with required delivery dates set for September 2026. Shipping is designated as FOB Destination, and the contractor must adhere to specific marking and labeling standards, including MIL-STD-129 and ASTM D3951 for non-hazardous materials.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

POVIDONE-IODINE CLEANS

Solicitation # SPE2DP-26-T-4856

This contract is for the procurement of Povidone-Iodine Cleansing Solution, USP 7.5%, supplied in one-gallon bottles. The product is regulated by the FDA and must be stored at 25 degrees Celsius, with permitted excursions between 15 and 30 degrees Celsius. A critical requirement is the shelf life, which is 36 months total, with at least 31 months remaining at the time of delivery to the first government activity. The agreement includes three separate line items totaling 13 bottles to be delivered to the USNS Billy Frank Jr, USS Ashland, and USS Springfield. Delivery is required within five days, and the shipping terms are FOB Destination. Suppliers must comply with DLA packaging and marking standards, including Medical Marking Standard No. 1, and must provide Safety Data Sheets and hazardous communication labels in accordance with OSHA and Federal Standard No. 313-E.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CHARCOAL, ACTIVATED, SUS

Solicitation # SPE2DP-26-T-4794

Solicitation SPE2DP-26-T-4794 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Activated Charcoal Suspension, identified by NSN 6505-01-282-8880. The requirement consists of four line items totaling 61 bottles, with each bottle containing 240 ML. Delivery is required within 20 days after receipt of order, with destination points including the USS KIDD DDG 100, Fort Bragg NC, and an FPO address in AP. The items must have a shelf life of 36 months, and no more than five months may have elapsed from the date of manufacture to the date of delivery to the government. Technical requirements specify that the material must be stored at 20 to 25 degrees Celsius and marked according to Medical Marking Standard No. 1. Packaging must be commercial and sealed to protect contents from damage, with palletization following RP001 DLA Packaging Requirements. Labels must include the NSN, manufacturer and CAGE code, date of manufacture, expiration or retest date, and the contract or lot number. Invoicing and receiving reports must be processed electronically through the Wide Area WorkFlow system. The solicitation incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, hazardous material identification, and cybersecurity safeguarding.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

TEST STRIPS AND COLOR

Solicitation # SPE2DS-26-T-415G

This contract is for the procurement of medical test strips and color charts used to analyze bilirubin, blood, glucose, ketones, leukocytes, nitrite, pH, protein, specific gravity, and urobiligen in urine. The items are issued in bottles containing 100 strips each, with a total quantity of two bottles requested under solicitation SPE2DS-26-T-415G. Delivery is required within 20 days after receipt of the order. The supplies must adhere to strict quality and packaging standards, including Medical Marking Standard No. 1 and DLA packaging requirements. A critical shelf-life requirement of 18 months applies, with a mandate that no more than two months may have elapsed from the date of manufacture to the date of delivery. All labels must clearly display the date of manufacture, expiration or retest date, and the contract or lot number.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 10 hours ago

DEADLINE

in 6 days

AI Contract Overview

This contract, identified by solicitation number SPE2DP-26-T-4800, is issued by the Department of Defense Medical Supply Chain Pharma FSA for the procurement of Dibucaine Ointment USP. The product contains 1 percent of dibucaine ointment as the active ingredient and is supplied in a collapsible tube with a rectal applicator for external use. Each unit of issue consists of a package containing one ounce or 28 grams. The item must be stored at temperatures between 15 and 30 degrees Celsius (59 to 86 degrees Fahrenheit) and has a non-extendable shelf life of 36 months. The procurement is for one package under NSN 6505-00-299-9535, with a delivery requirement of 20 days after order. The contract specifies delivery, inspection, and acceptance at the destination, with a zero percent quantity variance. The product is regulated by the FDA and must adhere to DLA packaging requirements, Medical Marking Standard No. 1, and specific quality standards outlined in the DLA Master List of Technical and Quality Requirements. The place of performance is listed as Fort Stewart, Georgia.

General Info

DoD procurement of Dibucaine Ointment for delivery to Fort Stewart, Georgia.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

BLDG 1509 WEST 6TH STREET, FORT STEWART, GA, 31314-5185, USA

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4800 RFQ for Quotations

PDF•24 pages•rfq

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedAug 31

Solicitation

Response DeadlineSep 8

Deadline has passed

Submission Closed

09/08/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressUSA

Contacts

Alec Deichman

contact@example.gov

+1 (555) 000-0000

Full Description

DIBUCAINE OINTMENT
DIBUCAINE OINTMENT<(>,<)> USP. CONTAINS 1 PERCENT OF DIBUCAINE OINTMENT
AS THE ACTIVE INGREDIENT. COMES SUPPLIED IN A COLLAPSIBLE TUBE AND
RECTAL APPLICATOR. RECTALLY ADMINISTERED. FOR EXTERNAL USE ONLY. UNIT OF
ISSUE IS A PACKAGE CONTAINING ONE (1) OUNCE OR 28 GRAMS. STORE AT 15-30
DEGREES CELSIUS OR 59 TO 86 DEGREES FARENHEIT.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
THE HARVARD DRUG GROUP, L.L.C. 1LEZ0 P/N NDC00536-1211-95
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018129152 0001 PG 1.000
NSN/MATERIAL:6505002999535
DELIVERY (IN DAYS):0020
SPE2DP-26-T-4800
SECTION B
PR: 7018129152 PRLI: 0001 CONT’D
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-00-299-9535 Quantity: 1 PG Purchase Request: 7018112857QTY: 1 Delivery: 20 days ADO